These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 16648100)

  • 1. Proteomic analysis in cancer research: potential application in clinical use.
    García-Foncillas J; Bandrés E; Zárate R; Remírez N
    Clin Transl Oncol; 2006 Apr; 8(4):250-61. PubMed ID: 16648100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic cancer classification with mass spectrometry data.
    Rajapakse JC; Duan KB; Yeo WK
    Am J Pharmacogenomics; 2005; 5(5):281-92. PubMed ID: 16196498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomics for cancer biomarker discovery.
    Srinivas PR; Verma M; Zhao Y; Srivastava S
    Clin Chem; 2002 Aug; 48(8):1160-9. PubMed ID: 12142368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncoproteomics.
    Joshi S; Tiwari AK; Mondal B; Sharma A
    Clin Chim Acta; 2011 Jan; 412(3-4):217-26. PubMed ID: 20955692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomic Approaches for Biomarker Panels in Cancer.
    Tanase C; Albulescu R; Neagu M
    J Immunoassay Immunochem; 2016; 37(1):1-15. PubMed ID: 26565430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SELDI proteinchip MS: a platform for biomarker discovery and cancer diagnosis.
    Wright GL
    Expert Rev Mol Diagn; 2002 Nov; 2(6):549-63. PubMed ID: 12465452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomic technologies and their application to pancreatic cancer.
    Vimalachandran D; Costello E
    Expert Rev Proteomics; 2004 Dec; 1(4):493-501. PubMed ID: 15966844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer proteomics: from biomarker discovery to signal pathway profiling.
    Bichsel VE; Liotta LA; Petricoin EF
    Cancer J; 2001; 7(1):69-78. PubMed ID: 11269650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical proteomics and mass spectrometry profiling for cancer detection.
    Solassol J; Jacot W; Lhermitte L; Boulle N; Maudelonde T; Mangé A
    Expert Rev Proteomics; 2006 Jun; 3(3):311-20. PubMed ID: 16771703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of proteomics in cancer gene profiling: two-dimensional difference in gel electrophoresis (2D-DIGE).
    Hariharan D; Weeks ME; Crnogorac-Jurcevic T
    Methods Mol Biol; 2010; 576():197-211. PubMed ID: 19882264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteome analysis for the identification of tumor-associated biomarkers in gastrointestinal cancer.
    Fels LM; Buschmann T; Meuer J; Reymond MA; Lamer S; Röcken C; Ebert MP
    Dig Dis; 2003; 21(4):292-8. PubMed ID: 14752218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategies for discovering novel cancer biomarkers through utilization of emerging technologies.
    Kulasingam V; Diamandis EP
    Nat Clin Pract Oncol; 2008 Oct; 5(10):588-99. PubMed ID: 18695711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomics to diagnose human tumors and provide prognostic information.
    Ornstein DK; Petricoin EF
    Oncology (Williston Park); 2004 Apr; 18(4):521-9; discussion 529-32. PubMed ID: 15134357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical proteomics for cancer biomarker discovery and therapeutic targeting.
    Krieg RC; Paweletz CP; Liotta LA; Petricoin EF
    Technol Cancer Res Treat; 2002 Aug; 1(4):263-72. PubMed ID: 12625785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The molecular make-up of a tumour: proteomics in cancer research.
    Kolch W; Mischak H; Pitt AR
    Clin Sci (Lond); 2005 May; 108(5):369-83. PubMed ID: 15831087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular profiling of cancer.
    Gillespie JW; Gannot G; Tangrea MA; Ahram M; Best CJ; Bichsel VE; Petricoin EF; Emmert-Buck MR; Chuaqui RF
    Toxicol Pathol; 2004; 32 Suppl 1():67-71. PubMed ID: 15209405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Innovative proteomic approaches for cancer biomarker discovery.
    Faca V; Krasnoselsky A; Hanash S
    Biotechniques; 2007 Sep; 43(3):279, 281-3, 285. PubMed ID: 17907570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic and proteomic biomarkers for cancer: a multitude of opportunities.
    Tainsky MA
    Biochim Biophys Acta; 2009 Dec; 1796(2):176-93. PubMed ID: 19406210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomics in cancer.
    Reymond MA; Schlegel W
    Adv Clin Chem; 2007; 44():103-42. PubMed ID: 17682341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncoproteomics: Trials and tribulations.
    Zhou L; Li Q; Wang J; Huang C; Nice EC
    Proteomics Clin Appl; 2016 Apr; 10(4):516-31. PubMed ID: 26518147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.